Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▾	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
VRCA	Verrica Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$35.58M	-$17.89M	-50.3%	-72.3%	370.2%	-$1.68
VNDA	Vanda Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$216.10M	-$220.47M	-102.0%	-67.4%	8.7%	-$3.74
VKTX	Viking Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$359.64M	n/a	-56.3%	n/a	-$3.19
VERU	Veru Inc. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$22.73M	n/a	-124.0%	n/a	n/a
VERA	Vera Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$299.62M	n/a	-49.6%	n/a	-$4.66
VBIO	Valion Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.88M	n/a	-52.9%	n/a	n/a
UTHR	United Therapeutics Corp Manufacturing · Year ended 2025-12-31 · USD	$3.18B	$1.33B	41.9%	18.8%	10.6%	$27.86
URGN	UroGen Pharma Ltd. Manufacturing · Year ended 2025-12-31 · USD	$109.79M	-$153.49M	-139.8%	n/a	21.4%	n/a
UPB	Upstream Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.85M	-$143.44M	n/m	-42.2%	20.4%	-$2.66
UNCY	Unicycive Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.55M	n/a	-87.9%	n/a	-$1.67
TYRA	Tyra Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$119.95M	n/a	-46.3%	n/a	-$2.01
TXMD	TherapeuticsMD, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.02M	-$569.0K	-18.8%	-2.1%	71.6%	-$0.05
TVTX	Travere Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$490.73M	-$25.55M	-5.2%	-22.2%	110.5%	-$0.29
TVRD	Tvardi Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$18.21M	n/a	-87.0%	n/a	-$3.26
TTRX	Turn Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$3.19M	n/a	-68.2%	n/a	-$0.12
TRVI	Trevi Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$42.76M	n/a	-23.3%	n/a	-$0.32
TRDA	Entrada Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$25.42M	-$143.75M	-565.5%	-47.0%	-87.9%	-$3.47
TRAW	Traws Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$9.17M	n/a	n/a	n/a	$0.82
TPST	Tempest Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.26M	n/a	-393.9%	n/a	-$6.33
TOVX	Theriva Biologics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$23.74M	n/a	-154.3%	n/a	-$2.08
TNXP	Tonix Pharmaceuticals Holding Corp. Manufacturing · Year ended 2025-12-31 · USD	$13.11M	-$124.02M	-946.2%	-50.6%	29.8%	-$14.57
TNGX	Tango Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$62.38M	-$101.59M	-162.9%	-29.3%	48.3%	-$0.87
TLPH	Talphera, Inc. Manufacturing · Year ended 2025-12-31 · USD	$28.0K	-$14.29M	n/m	-83.9%	n/a	n/a
TGTX	TG Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$616.29M	$447.18M	72.6%	69.0%	87.3%	$2.77
TEVA	Teva Pharmaceutical Industries Ltd Manufacturing · Year ended 2025-12-31 · USD	$17.26B	$1.41B	8.2%	17.8%	4.3%	$1.21

Rows per page: 2550 100